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Abstract
Flexibility in study designs, definitions, outcomes and analytic 
models increases the chance that the results reported in an empirical 
study are untrue. Such flexibility in methodological and analytic 
practices has been observed in evaluations of a number of drug 
prevention programs that appear on lists of evidenced-based 
programs. The current paper examines the evidence base pertaining 
to one of the most well-established drug prevention programs, namely 
the Midwestern Prevention Project (MPP; also known as Project 
STAR). Specifically, it examines the results reported from the quasi-
experimental evaluation of the MPP that was conducted in Kansas City 
and the experimental replication conducted in Indianapolis, Indiana, 
and the data analysis practices used in producing these findings. It 
shows there is considerable analytical flexibility evident in the published 
accounts from these two evaluations studies, notably in the samples 
used in the data analyses and the manner in which outcome variables 
were measured. The implications of this for the MPP’s status as an 
evidenced-based drug prevention program are discussed, along with 
the means by which flexibility in analytic procedures in drug prevention 
research could be reduced. The seemingly widespread existence of 
such analytic flexibility within the field suggests that confirmation bias is 
part of the general culture of drug prevention research. This impedes 
the development of a sound scientific base within the discipline and 
might even lead it to degenerate into a pseudoscience.
Introduction
Ioannidis [1] recently noted that the greater the flexibility in study 
designs, definitions, outcomes and analytic models, the less likely it is 
that research findings are true. Elaborating further, he observed that 
flexibility in the case of analytic methods allows “experimentation” 
in data analysis and the option to report only the “best” results. In 
the case of outcomes, flexibility is greatest when these can take many 
different forms and can be measured in many different ways (e.g., 
scales that can be dichotomized at different points). This gives the 
researcher more freedom to choose the measure that produces the 
“best” result.
A number of case studies have observed the presence of such 
flexibility in the methodological and analytic practices employed 
in evaluations of drug prevention programs [2-7]. Summarizing 
this literature, Holder [8] highlighted the frequent use of 1-tailed 
tests of statistical significance, post hoc outcome variable selection, 
obfuscation of selection bias, and exaggeration of statistically 
significant effects that are of little or no clinical significance. He 
also noted that critical debate over the use of such practices and the 
interpretation of study findings was largely absent from the drug 
prevention field and that this was likely to impede the development 
of a sound scientific base to the discipline.
The current paper examines in detail the evidence base pertaining 
to one of the most well-established drug prevention programs, namely 
the Midwestern Prevention Project (MPP; also known as Project 
STAR). The MPP developer recently described it as an “evidence-
based program for prevention of both drug use and violence” [9], 
noting that it had been selected for inclusion on two high profile 
lists of model programs (the University of Colorado’s Blueprints for 
Violence Prevention [10,11] and the Substance Abuse and Mental 
Health Service Administration’s National Registry of Evidence-
based Programs and Practices [12]). In addition, the MPP has also 
been included in the National Institute on Drug Abuse’s Research-
based Guide [13] and the Promising Programs Network’s Programs 
that Work [14], and was listed as a model risk prevention program 
by the US Department of Health and Human Services in its Surgeon 
General’s report on youth violence [15]. The fundamental contention 
of the present paper is that the MPP would not be considered an 
evidence-based or model drug prevention program were it not for the 
use of the type of flexible analytic practices described by Ioannidis [1].
The evidence pertaining to the MPP comes from two National 
Institute on Drug Abuse (NIDA) funded evaluation studies that 
began in the mid-1980s [16]. The first evaluation, which used a quasi-
experimental design, was conducted in Kansas City and started in 
1984. The second, which used an experimental design, was conducted 
in Indianapolis, Indiana and commenced in 1987. The Kansas City 
quasi-experiment has been much more extensively reported-on in the 
peer-review literature than the Indianapolis experiment.
The Kansas City Quasi-Experimental Evaluation of the 
Midwestern Prevention Project
The MPP was designed as a multicomponent community-based 
program with sequential introduction of five components: a mass 
media campaign, a school-based curriculum, a parent program, 
community organization involving training of city leaders in the 
planning and implementation of prevention efforts, and a health 
policy component designed to initiate change in local ordinances 
regulating the availability of alcohol and tobacco products [10,16,17]. 
The school-based component involved 10 to 13 skills training 
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sessions taught in 6th or 7th grade, with a five-session booster program 
the following year.  The training was dedicated to the development 
of drug-specific resistance skills, and addressed the psychosocial 
consequences of drug use, beliefs about drug use prevalence, 
recognition of adult, media and community influences supportive of 
drug use, peer and environmental pressures, assertiveness training 
and problem-solving in difficult situations. The parent component 
was orientated around ten homework assignments which involved 
interviewing family members about techniques for avoiding alcohol 
and drug use and family methods used to counteract media and 
community influences. The mass media component included 16 
television, 10 radio and 30 print media events, but these were present 
in both the intervention and comparison conditions. These program 
activities were implemented over the course of a 17-month period 
[16].
The baseline sample of the Kansas City study comprised some 
5,000 students, of whom 1,607 were tracked individually over the 
course of the study (this figure is given as 1,606 in some publications 
from the study) and the remainder tracked by grade cohort (including 
new intake students who may not have received the intervention). The 
samples were assessed at baseline (September 1984) when subjects 
were in 6th or 7th grade (aged 12 or 13 years), and at least some of 
the subjects have been followed-up on 15 subsequent occasions into 
“early adulthood” (27 through 34 years) [17]. Despite this wealth of 
data collection, there have been just two periods of time in which 
findings from the MPP Kansas City evaluation have been published, 
first between 1989 and 1991 (focused on either the panel sample or 
grade cohort) and then, 18 years later, in 2009 (focused on the panel 
sample).
Effects on Cigarette, Alcohol and Marijuana Use at the 1-, 
2- and 3-Year Follow-ups
The foci of the initial papers published from the Kansas City 
quasi-experimental evaluation of the MPP were cigarettes, alcohol 
and marijuana use at the 1-year follow-up [16,18-20], the 2-year 
follow-up [21-23] and the 3-year follow-up [24]. Tables 1 through 
3 summarize the findings from these publications.  Each table shows 
which sample was used in the data analysis reported in the paper 
(panel or combined) and the specific outcome for each type of drug 
reported (i.e., past-week use, past-month use, and, in the case of 
cigarettes, “other”).
With the exception of Dwyer et al. [20], all of the publications 
state that they use 1-tailed tests of statistical significance. Use of 
1-tailed tests of statistical significance in evaluating drug prevention 
programs doubles the threshold for rejecting the null hypothesis 
of no effect and involves making the claim that a program cannot 
produce iatrogenic effects [8,25]. However, as noted by Valente et al. 
[26], it is largely impossible to entirely rule out the occurrence of the 
latter, and iatrogenic effects have indeed been reported in evaluations 
of a number of prominent drug prevention programs that appear on 
evidence-based lists [e.g., 26-28]. Since the focus of the present paper 
is on how analytic flexibility can increase the chance of generating 
positive results it seemed reasonable to distinguish those findings 
reported in the MPP Kansas City evaluation that would have been 
statistically significant had the analyses employed the traditional 
2-tailed test of statistical significance from those that would not 
be statistically significant using such a test (i.e., those that are only 
statistically significant using the more lenient 1-tailed test). In the 
case of six of the eight publications from the evaluation [16,18,19,21-
23] this meant distinguished those results reported as statistically 
significant at p < 0.01 (using a 1-tailed test) from those results 
statistically significant at p <0.05 (using a 1-tailed test). The former 
was considered a statistically significant positive effect and denoted by 
a “” in tables 1 to 3, whereas the latter was considered a questionable 
statistically significant effect and denoted by a “?” in the tables. Where 
no statistically significant effect was reported (including p values of 
0.10 using 1-tailed tests, as in two of the publications [22,23]), a “” 
appears in the tables. With regard to the remaining two publications, 
Johnson et al. [24] reported exact p values, one of which (for cigarette 
use) would have been statistically significant using a 2-tailed test of 
statistical significance, one of which (for alcohol use) would not, 
and one of which (for marijuana use) was of questionable statistical 
significance. Accordingly, a “”, a “”, and a “?” appear in each of the 
respective tables. Finally, in the case of Dwyer et al. [20], no effect on 
alcohol use was reported (hence “” appears in Table 2), along with a 
reduction in the prevalence of cigarette users and mixed evidence of 
an effect on marijuana use (each of which is interpreted as a positive 
effect in Table 1 and Table 3, respectively).
As shown in Table 1, each of the eight publications published 
between 1989 and 1991 contained data pertaining to cigarette use, 
with seven of these presenting data from the 1-year follow-up, three 
data from the 2-year follow-up, and one data from the 3-year follow-
up. Four of the five studies that reported findings from the combined 
sample at the 1-year follow-up found a statistically significant effect 
on cigarette use during the previous month [16,19,21,22]. The effects 
on use during the previous week and the “other” outcome variables 
were less impressive as it is uncertain whether most of these would 
be statistically significant had 2-tailed tests been employed in the 
statistical analysis. Just one study [22] reported results for cigarette 
use at the 2-year follow-up from the combined sample, and none of 
the three findings presented would have been statistically significant 
using 2-tailed tests. Two publications reported results from the panel 
sample at the 1-year follow-up [20,23] and two at the 2-year follow-
up [21,23]. The majority of these results were statistically significant, 
as was the single result reported from the 3-year follow-up [24].
Table 2 shows the results for alcohol use from the six studies 
that reported on this outcome. Most of the results pertained to the 
combined sample at the 1-year follow-up: three of these results were 
statistically significant, while four were of questionable significance 
[16,18-21]. Results from the panel sample are sparse: Dwyer et al. [20] 
reported results for past-week use at the 1-year follow, Pentz et al. 
[21] reported results for past-month use at the 2-year follow-up, and 
Johnson et al. [24] reported results for past-month use at the 3-year 
follow-up. Only the result at the 2-year follow-up was statistically 
significant.
Table 3 shows the results from the six publications that reported 
effects on marijuana use. Of the five that reported results from the 
1-year follow, just one found a statistically significant effect on 
past-month use in the combined sample [19] and one a statistically 
significant effect on past-week use in the panel sample [20]. The 
results reported in the other three studies for the 1-year follow-up 
all pertain to past-week and past-month use among the combined 
sample and each of them is of questionable statistical significance 
(i.e., it is unclear whether they would be statistically significant had 
2-tailed tests been used in the data analysis) [16,18,21]. One study 
reported results on past-month use at the 2-year follow-up [21] and 
one at the 3-year follow-up [24] using data from the panel sample 
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Sample used Year 1d Year 2 Year 3
in Analysis b Otherc Week Month Otherc Week Month Other Week Month
Pentz et al. [16]e Panel --- --- ---
Combined -- ? 
Pentz et al. [18]f Panel --- --- ---
Combined -- ? ?
MacKinnon et al. [19]g Panel --- --- ---
Combined --- --- 
Dwyer et al. [20]h Panel ---  ---
Combined --- --- ---
Pentz et al. [21]i Panel --- --- --- --- --- 
Combined ---   --- --- ---
Pentz et al. [22]j Panel --- --- --- --- --- ---
Combined ? ?    ?
Pentz et al. [23]k Panel  ?  ?  
Combined --- --- --- --- --- ---
Johnson et al. [24]l Panel --- --- 
Combined --- --- ---
Table 1: Statistically Significant Program Effects on Cigarettes Use Reported in Publications from the First Three Years of the MPP Evaluationa
Note: a --- = data analysis not reported;  = statistically significant positive effect reported (i.e., p values < 0.01 using 1-tailed tests); ? = questionable statistically 
significant effect (i.e., p values of <0.05 using 1-tailed tests);  = no statistically significant effect reported.
b Combined = approximately 5,000 tracked individually and by grade cohort; Panel = 1607 students tracked individually.
c  All of the studies report “past week” and/or “past month” use as an outcome variable. Two studies report one additional outcome measure: “past day” use [22] and 
“current” use [23]. These outcomes are listed under the column “other”.  In addition, these studies, along with Pentz et al. [18], report data pertaining to “lifetime use”. 
This is not included in the table, as it is primarily an indicator of “background drug use experience prior to intervention” not as a dependent variable measuring program 
effects [18, p. 271].
d Two papers also contain data pertaining to a 6-month follow-up. Pentz et al. [21] contains a figure that includes 6-month follow-up data, but presents no statistical 
analysis of these [21, figure 1 and table 1]. Pentz et al. [23] contains statistical analysis of data from the 6-month follow-up (with results similar to those of the 1-year 
follow-up).
e Data from adjusted analysis reported in Pentz et al. [16, table 4].
f Data from Pentz et al. [18, table 3] which reports results for 12 schools with a high level of program implementation and 12 schools with a low level of implementation. 
The former results are reported in the above table as these were more favorable to the program.
g Data from MacKinnon et al. [19, p. 168, column 2].
h Dwyer et al. [20] used a number of different models in their analysis and concluded that these showed a reduction in the prevalence of cigarette users in the MPP 
schools compared to the controls [20, p. 781]. Hence “” appears in the table.
i Data for the 1-year follow-up are from Pentz et al. [21, table 1]. The analysis of the 2-year follow-up data does not present exact cut-offs for p values (e.g., p <0.05). 
Rather it is stated that the values for cigarette use, marijuana use and alcohol use each fall between <0.05 and 0.001 (using 1-tailed tests) and a figure is presented 
that shows prevalence of use in the last month [21, figure 1]. One cannot determine from this if the difference reported for cigarette use would be statistically significant 
at p <0.05 (using a 2-tailed test). However, since the effect at 1-year was said to be “maintained” [21, pp.220-221], a “” appears in the above table.
j Data reported are from the analysis of longitudinal program effects using endpoint schools [22, table 2, column 9 and table 3, column 9].
k Data pertaining to “past week” use and “past month” use are from the adjusted analysis reported in Pentz et al. [23, table 4]. Data pertaining to current use are from 
Pentz et al. [23, p. 721).
l Data from Johnson et al. [24, table 1].
[21,24]. Again, it is uncertain if these findings would be statistically 
significant had 2-tailed tests been employed in the analysis and hence 
they are designated as of questionable statistical significance in the 
table.
Other than the findings pertaining to use of cigarettes in the 
previous month, the results presented in tables 1 through 3 can hardly 
be said to present a compelling case that the MPP prevents drug 
use among adolescents. However, of most relevance to the current 
paper’s analysis of analytic flexibility is that the focus of the Kansas 
City evaluation narrowed after the first-year follow-up both in terms 
of the subjects included in the analysis and the outcomes reported. 
Most notably, no results pertaining to alcohol and marijuana use 
were reported for the combined sample at the second or third year 
follow-up and the results that were reported for the panel sample 
were all derived from a very simple dichotomous measure of use 
during the previous month. Interestingly, two of the three findings 
reported by Pentz et al. [22] for cigarette use at the 2-year follow-up 
using the combined sample were not statistically significant even with 
the use of 1-tailed tests of statistical significance, and the focus of the 
evaluation for this outcome variable also shifted to the panel sample 
at this point. Thus, by the 3-year follow-up the data reported for all 
three drugs were limited to just the panel sample and to the simple 
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Table 2: Statistically Significant Program Effects on Alcohol Use Reported in Publications from the First Three Years of the MPP Evaluationa
Sample used Year 1c, d Year 2 Year 3
In Analysis b Week Month Week Month Week Month
Pentz et al. [16]e Panel --- ---
Combined ? 
Pentz et al. [18]f Panel --- ---
Combined ? ?
MacKinnon et al. [19]g Panel --- ---
Combined --- ?
Dwyer et al. [20]h Panel  ---
Combined --- ---
Pentz et al. [21]i Panel --- --- --- 
Combined   --- ---
Johnson et al. [24]j Panel --- 
Combined --- ---
Note: a --- = data analysis not reported;  = statistically significant positive effect reported (i.e., p values < 0.01 using 1-tailed tests); ? = questionable statistically 
significant effect (i.e., p values of <0.05 using 1-tailed tests);  = no statistically significant effect reported.
b Combined = approximately 5,000 tracked individually and by grade cohort; Panel = 1607 students tracked individually.
c  Only two columns of outcome variables are shown in the table for each follow-up period, since neither of the reports that included an additional outcome measure 
[22,23] reported any data pertaining to alcohol use. Pentz et al. [18] reported results pertaining to “lifetime use” but this is not included in the table as it is primarily an 
indicator of “background drug use experience prior to intervention” not as a dependent variable measuring program effects [18, p. 271].
d Two papers also contain data pertaining to a 6-month follow-up. Pentz et al. [21] contains a figure that includes 6-month follow-up data, but presents no statistical 
analysis of these [21, figure 1 and table 1]. Pentz et al. [23] contains statistical analysis of data from the 6-month follow-up (with results similar to those of the 1-year 
follow-up).
e Data from adjusted analysis reported in Pentz et al. [16, table 4].
f Data from Pentz et al. [18, table 3] which reports results for 12 schools with a high level of program implementation and 12 schools with a low level of implementation. 
The former results are reported in the above table as these were more favorable to the program.
g Data from MacKinnon et al. [19, p. 168, column 2].
h Dwyer et al. [20] used a number of different models in their analysis and concluded that these showed “no evidence of an effect on alcohol use” [20, p. 781].  Hence 
“” appears in the table.
 i Data for the 1-year follow-up are from Pentz et al. [21, table 1]. The analysis of the 2-year follow-up data does not present exact cut-offs for p values (e.g., p <0.05). 
Rather it is stated that the values for cigarette use, marijuana use and alcohol use each fall between <0.05 and 0.001 (using 1-tailed tests) and a figure is presented 
that shows prevalence of use in the last month [21, figure 1]. One cannot determine from this if the difference reported for alcohol use would be statistically significant 
at p <0.05 (using a 2-tailed test). However, since the effect at 1-year was said to be “strengthened slightly” [21, p.221], a “” appears in the table.
j Data from Johnson et al. [24, table 1].
dichotomous measure of use in the previous month.  This narrowing 
down of drug use outcomes to just one fairly crude measure is curious 
since subjects were in 9th and 10th grade by this time and one might 
reasonably have expected some results pertaining to more regular 
consumption and/or heavy use of the three drugs to be reported. 
Indeed, since a number of subjects were using drugs by this time (34% 
drinking alcohol during the previous month, 25% smoking cigarettes, 
and 12% smoking marijuana) [24], regular and heavy use of these 
substances were likely occurring among the sample.
Drug Use and Other Outcomes at Later Follow-ups
Table 4 summarizes the follow-up assessments and objectives of 
the three recent publications that have emerged from the MPP Kansas 
City quasi-experiment [9,17,29]. Each of these publications analyzed 
data from random samples of either 1,002 or 541 subjects drawn 
from the 1,607 individuals in the original panel sample. One thing 
that immediately stands out from the table is that there have been 13 
follow-up assessments of these subjects since the 3-year follow-up in 
9th or 10th grade reported in Johnson et al. [24].  They were followed 
up on two more occasions in high school (10th/11th grade and 11th/12th 
grade), five times during “emerging adulthood” (19 through 26 
years), and four times during “early adulthood” (26 through 30-34 
years) [17]. And yet just three publications have been produced from 
what one can only assume to be a wealth of data. In addition, none of 
these three publications contains an account of the effects of the MPP 
on the three drugs that were the primary outcomes of the evaluation, 
namely cigarettes, alcohol and marijuana. Rather, what have been 
reported in these publications are the effects of involvement in the 
program on very specific outcomes assessed at various points in 
time during the more than 20 years of data collection. Riggs et al. 
[29], for example, report the effects of the MPP on amphetamine use 
using data from 13 of the assessment points. Growth curve analysis 
showed delayed initiation of amphetamine use among those who 
participated in the MPP compared to the control subjects and a 
continued reduction in the growth in amphetamine use beginning 
in high school (assessments 3-6) and continuing into emerging and 
early adulthood (assessments 7-14).
In an even more narrowly focus analysis, Riggs and Pentz [9] 
examined whether the MPP’s effects on marijuana use during high 
school (assessments 4 to 6) mediated its influence on utilization 
of mental health services in adulthood among 961 subjects who 
provided data at either assessments point 13 or 14. Structural equation 
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Table 3: Statistically Significant Program Effects on Marijuana Use Reported in Publications from the First Three Years of the MPP Evaluationa
Sample used Year 1c,d Year 2 Year 3
In Analysis b Week Month Week Month Week Month
Pentz et al. [16]e Panel --- ---
Combined ? ?
Pentz et al. [18]f Panel --- ---
Combined ? ?
MacKinnon et al. [19]g Panel --- ---
Combined --- 
Dwyer et al. [20]h Panel  ---
Combined --- ---
Pentz et al. [21]i Panel --- --- --- ?
Combined ? ? --- ---
Johnson et al. [24]j Panel --- ?
Combined --- ---
Note: a  --- = data analysis not reported;  = statistically significant positive effect reported (i.e., p values < 0.01 using 1-tailed tests); ? = questionable statistically 
significant effect (i.e., p values of <0.05 using 1-tailed tests);  = no statistically significant effect reported.
b Combined = approximately 5,000 tracked individually and by grade cohort; Panel = 1607 students tracked individually.
c  Only two columns of outcome variables are shown in the table for each follow-up period, since neither of the reports that included an additional outcome measure 
[22,23] reported any data pertaining to marijuana use.  Pentz et al. [18] reported results pertaining to “lifetime use” but this is not included in the table as it is primarily 
an indicator of “background drug use experience prior to intervention” not as a dependent variable measuring program effects [18, p. 271].
d  Two papers also contain data pertaining to a 6-month follow-up.  Pentz et al. [21] contains a figure that includes 6-month follow-up data, but presents no statistical 
analysis of these [21, figure 1 and table 1].  Pentz et al. [23] contains statistical analysis of data from the 6-month follow-up (with results similar to those of the 1-year 
follow-up).
e  Data from adjusted analysis reported in Pentz et al. [16, table 4].
f  Data from Pentz et al. [18, table 3] which reports results for 12 schools with a high level of program implementation and 12 schools with a low level of implementation. 
The former results are reported in the above table as these were more favorable to the program.
g   Data from MacKinnon et al. [19, p. 168, column 2].
 h Dwyer et al. [20] used a number of different models in their analysis and concluded that these showed “mixed evidence of an effect on marijuana use” [20, p. 781). 
This is interpreted as a statistically significant positive effect on marijuana use (i.e., “” appears in the table).
i  Data for the 1-year follow-up are from Pentz et al. [21, table 1].  The analysis of the 2-year follow-up data does not present exact cut-offs for p values (e.g., p <0.05). 
Rather it is stated that the values for cigarette use, marijuana use and alcohol use each fall between <0.05 and 0.001 (using 1-tailed tests) and a figure is presented that 
shows prevalence of use in the last month [21, figure 1].  One cannot determine from this if the difference reported for marijuana use would be statistically significant 
at p <0.05 (using a 2-tailed test). However, but since the effect at 1-year was said to be “maintained” [21, pp.220-221], a “?” appears in the table.
 j Data from Johnson et al. [24, table 1].
modeling demonstrated such a meditational effect, which the authors 
interpreted as supporting “…the role of early adolescent drug use 
prevention programs in impacting later mental health problems” 
[9]. Riggs et al. [17] used the same methods to assess the effects of 
the MPP on marijuana use in early adulthood (assessment 12) and 
the subsequent effects of this on parent-child relationships and child 
impulsivity (assessment 14 or assessment 15). By this time the sample 
was reduced to just 541 subjects, of whom 257 had children in the 
age range for inclusion in the study. The analysis showed that the 
131 subjects assigned to the MPP condition used significantly less 
marijuana in early adulthood compared to the 126 subjects in the 
control group and that there was a direct relationship from parental 
marijuana use to child impulsivity as well as an indirect relationship 
through parent-child interactions. Despite the fact that these results 
were produced from data obtained from just 16% of the subjects 
originally included in the MPP panel sample, Riggs et al. conclude 
that they “can be interpreted as the sustained impact of the MPP on 
adult marijuana use” and as “…suggesting that the MPP intervention 
contributed to lower levels of impulsivity in the children of original 
participants” [17].
Each of these later publications presents positive findings that 
the authors interpret as lending support to the idea that the MPP 
is an efficacious drug prevention program. However, each begs 
the question as to why these particular analyses were presented. A 
number of other “hard” drugs were assessed in the MPP evaluation, 
including cocaine, barbiturates and heroin [10]; so why do Riggs et al. 
[29] only focus on amphetamines? Use of alcohol could mediate the 
effects of an intervention program on receipt of mental health services 
as an adult or on parent-child interactions and child impulsivity; so 
why do Riggs and Pentz [9] and Riggs et al. [17] only focus on the 
potential meditational effects of marijuana?  Why examine the effects 
of baseline marijuana use in one of these studies [17] but marijuana 
use during high school in the other [9]? Why use measurement points 
13 and 14 to assess the outcome in one study [9] but 12 and 14 or 15 
in the other [17]? Without clear answers to such questions one cannot 
be sure that the results presented in these recent publications from 
the Kansas City evaluation of the MPP are not analysis-driven rather 
than the result of by a priori hypothesis testing.
A Final Example from the Kansas City Evaluation
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The analysis presented so far suggests that there has been a great 
deal of analytic flexibility in the reporting-out of results from data 
collected in the Kansas City MPP evaluation. A further illustration 
of this practice can be found in another paper published in the mid-
2000s that used data from the evaluation to examine the effects of 
parent participation in the parent education components of the MPP 
on their perceptions of their influence over their children’s drug use 
at the 2-year follow-up [30]. The data used in the analysis reported 
in this study came from a group of 351 parents of the 1,607 students 
in the panel sample. This group comprised just 28% of the 1,267 
parents eligible to take part in the study at baseline.  The analysis 
presented showed that the 233 parents who reported being in the 
MPP parenting program had significantly greater perceived influence 
over their children’s drug use than the 118 parents who reported no 
participation, and this result was said to have “provided support for 
the effectiveness of the parent component of the MPP in changing 
parent perceptions of their children’s substance use” [30].
As with the other more recent analyses that have emerged from 
the MPP Kansas City evaluation those presented by Riggs et al. [30] 
pertaining to involvement in the MPP parenting program raise 
numerous questions. For example, why are data reported for just 
the 2-year follow-up, and not the 1-year or 3-year follow-ups? Why 
is perceived parental control over adolescent drug-use the outcome 
variable and not the actual drug use of the participants’ children who 
were in the MPP study? But by far the greatest indicator of analytic 
flexibility in this particular analysis is the manner in which the 
investigators construct the “MPP group” and the “control” group. As 
noted above, the panel sample of the MPP evaluation involved 1,607 
children (and their parents) from eight schools that were randomly 
allocated to either receive the program (n=904) or not (n=703). 
That is, the investigators used standard research practices to create 
an intervention group and a control group. However, the analysis 
presented by Riggs et al. [30] completely abandoned this design: any 
parent who reported participation (regardless of whether he/she was 
from the intervention group or the control group) was included in 
the MPP group and was compared to any parent who did not report 
participation (regardless of whether he/she was from the intervention 
group or the control group). This would seem to be a textbook 
example of what Ioannidis [1] calls flexibility in study design.
The Indianapolis Experimental Evaluation of the 
Midwestern Prevention Project
The MPP Indianapolis replication study began in 1987 and 
involved 3,412 students in 6th and 7th grade at baseline (1,904 in the 
MPP group and 1,508 in the control group) [31]. No full account 
of the results of the Indianapolis experiment has been published. 
The data have been used to examine predictors of attrition over the 
course of the follow-up [32], parental substance use as a modifier of 
adolescent use [33], the characteristics of different types of community 
coalitions for alcohol and drug prevention [34], and the effects of 
parental participation in the parenting component of the program on 
children’s drug use [35], but the effects of student participation in the 
main school-based component of the MPP on subsequent drug use 
are largely unknown.
The only published account to examine subsequent drug use 
of participants in the MPP Indianapolis replication focused on the 
“secondary” prevention effects of the program on those individuals 
who were already using cigarettes (n=400; 12% of the total sample), 
alcohol (n=613; 18% of the total sample) or marijuana (n=60; 1.8% of 
the total sample) in the previous month at baseline [31]. Subjects were 
followed-up at 6, 18, 30 and 42 months and statistically significant 
differences between the MPP group and the control group were 
observed at two of the four follow-ups for both previous-month 
cigarette use (the 6- and 30-month follow-up) and previous-month 
alcohol use (the 6- and 18-month follow-ups).  This led the authors 
to conclude “…that social influence-based primary prevention 
programs can have an impact on not only students who are nonusers 
at baseline but also those who have began to use drugs” [31]. This 
conclusion largely overlooks the fact that the effects on alcohol use 
were short-lived and that there were no effects on marijuana use. 
Moreover, there is nothing in the MPP Indianapolis replication study 
to indicate that it has any effect on the drug use of baseline nonusers 
(i.e., the vast majority of those who took part in the study).
Conclusions
The above review of the results presented in publications from 
the two evaluations of the MPP shows that there is little evidence 
to indicate that the program had anything other than short-term 
effects cigarette use. With regard to the specific issue of flexibility in 
study design, definitions, outcomes and analytic models the focus 
of the Kansas City MPP evaluation began to narrow after the 2-year 
follow-up both in terms of the subjects included in the analyses and 
the outcomes for which results were reported. This tendency became 
even more noticeable in the publications that used data from the later 
follow-up points of the study when subjects from the panel sample 
were in their twenties and thirties. Given the scope of information 
collected and the number of assessment points, the Kansas City MPP 
evaluation must contain a huge amount of data about participants’ 
Assessment Point
Middle School High School Emerging Adulthood Early Adulthood
Sample B/L 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Riggs et al. [29] 1002             
Growth in amphetamine use through high school, emerging adulthood and early adulthood controlling for an index of baseline 
cigarette, alcohol and marijuana use.
Riggs & Pentz [9] 961       
Marijuana use of subjects assessed at baseline and throughout high school.  Receipt of mental health services assessed at 
age 27 and age 28-30 (measurement points 13 and 14).
Riggs et al. [17] 257   
Marijuana use of subjects (parents) assessed at baseline and age 26 (measurement point 12).  Child-parent interactions and 
child impulsivity assessed at age 28-30 or 30-34 (measurement point 14 or 15).
Table 4: Variables and Assessment Points Included in Recent Publications from the Kansas City MPP Evaluation Study.
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drug use over more than a 20-year period, and yet just a few results 
have been reported. While such exploratory analyses are permissible, 
the results they produce should not be used (as they have been by 
the MPP evaluators) to make claims about the efficacy of the MPP 
as a prevention program. The piecemeal reporting of findings is even 
more noticeable in the Indianapolis replication study which has never 
published a paper that describes the effects of the program on the 
primary outcomes of cigarette, alcohol and marijuana use among 
the full sample. Commenting on this situation, Brian Flay (one of 
the evaluators on the MPP Kansas City study) observed that “…the 
lack of reported results from the Indianapolis replication, where the 
research design was stronger, leaves many questions unanswered and 
reflects negatively on the MPP study” [36].
It should be noted that such selective reporting of study findings 
within drug prevention research is not isolated to the MPP evaluation 
studies. Indeed, as Holder [2] warned, it is in danger of becoming 
normative within the field. It has been observed in the evaluations 
of the Life Skills Training program [3,5,37,38] the Seattle Social 
Development Project [5], Project ALERT [2,4,6] and the Strengthening 
Families Program [7,39]. Interestingly, it tends not to be found 
in independent replications of developer-led evaluations of drug 
prevention programs [e.g., 40,41]. This suggests that one condition 
that must be met before any program is designated “evidence-based” 
is that there be a truly independent replication study conducted by 
individuals with no ties to the program developers.
Ioannidis [1] observes that flexibility and selectivity in reporting 
of study findings is likely to be reduced by adherence to established 
standards for conducting and reporting controlled studies (e.g., those 
contained in the CONSORT statement [42]). Unfortunately, many 
of the journals that publish evaluation studies of drug prevention 
programs do not require registration with CONSORT. In addition, 
simply including a CONSORT style diagram of the follow-up of 
subjects over the course of a study (as was done in Riggs et al. [17,29]) 
does little to ensure the integrity of a study design, as it does nothing 
to prevent the selective reporting of study findings. Ultimately journal 
editors and reviewers are the key gatekeepers of research integrity 
within a field of inquiry and they must ensure that the claims made 
on behalf of a particular program are reasonable given the research 
design and analytic methods used to evaluate it and the outcomes 
reported. The MPP evaluation is one of the best know in the field of 
drug prevention studies since it was one of the earliest of the social 
influence programs to be studied, the findings from the early part 
of the study appeared in high profile journals, and the program has 
appeared on a number of evidence-based lists. Given this, it seems 
strange that those who reviewed the most recent publications from 
the Kansas City study would have been unaware that the results 
reported were selective and, in two cases, involved just a fraction of 
the subjects originally recruited into the study. In addition, it seems 
unlikely that the reviewers and editors would not have realized that 
the results presented in these papers were essentially the product of 
exploratory analyses that could not form the basis for making claims 
about the efficacy of the MPP. Again, suggests that confirmation bias 
is part of the general culture of the field of drug prevention research. 
Unless this changes, it is a field that will have no sound scientific base 
[2].
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